Virtus LifeSci Biotech Clinical Trials ETF
17 hedge funds and large institutions have $2.67M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$626K | |
| 2 | +$22.2K | |
| 3 | +$11.8K | |
| 4 |
ODG
O'Dell Group
Cincinnati,
Ohio
|
+$2.8K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.75K |